Congressional researchers released a report on Wednesday that provides a point-by-point overview of the limitations of President Joe Biden’s mass marijuana pardon, as well as broader analysis on recent state and federal cannabis reform actions. The Congressional Research Service (CRS) described the “two key developments in federal and state... Read more
A federal judge recently dismissed a lawsuit from Florida’s agriculture commissioner that challenges a ban on medical marijuana patients’ rights to buy and possess firearms—but the state official isn’t ready to give up the case just yet. Commissioner Nikki Fried (D) and her patient co-plaintiffs appealed the decision to the... Read more
Sen. Cory Booker (D-NJ) and Rand Paul (R-KY) filed a bill on Thursday that would require the Drug Enforcement Administration (DEA) to transfer breakthrough therapies like psilocybin and MDMA from Schedule I to II, while also removing research barriers for strictly controlled substances. The “Breakthrough Therapies Act” was filed... Read more
As of Tuesday, certain naloxone products like NARCAN have been evaluated by the U.S. Food and Drug Administration and determined to be safe enough to potentially be sold over the counter in the near future. “Today, the U.S. Food and Drug Administration issued a Federal Register notice, Safety and... Read more
A leader of Germany’s main opposition party took aim at the country’s proposal to decriminalize marijuana on Wednesday, asking the European Union to step in and block the plan. Klaus Holetschek, the health minister for a conservative-led state government in Germany, “met the EU’s director-general for migration and home... Read more
The U.S. Senate on Wednesday approved landmark legislation to expand medical marijuana research, marking the first time both chambers of Congress have passed a standalone cannabis bill. The measure, titled the Medical Marijuana and Cannabidiol Research Expansion Act, received the approval of the House of Representatives during the summer... Read more
Republican U.S. Congressman Pete Sessions (R-Texas) faces universal backlash from officials and NORML leadership after making “shameful” remarks comparing the cannabis industry with slavery at a House Oversight Committee hearing on November 15 in Washington, D.C. The Civil Rights and Civil Liberties Subcommittee of the House Oversight Committee gathered... Read more
Ahead of this week’s Marijuana Business Conference in Las Vegas, cannabis POS software company Treez is getting ready to bring its version of the future of retail cannabis FINtech to market with a series of product innovations. John Yang, CEO, Treez John Yang, Treez’s CEO, tells Cannabis Business Executive... Read more
